Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116768938B reveals iron catalyst technology for Rimegepant intermediates. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN103880790A details a green Pd-catalyzed oxidative coupling for bifurans. This method offers significant cost reduction in pharmaceutical manufacturing and superior scalability.
Patent CN112979563B details a recyclable ionic liquid method for high-purity pharmaceutical intermediates, offering significant cost reduction and simplified purification for global supply chains.
Novel 4-step metal-free synthesis of Fevipiprant intermediate. Reduces cost and improves purity for asthma drug manufacturing via patent CN108484595B.
Novel patent CN106588932B offers high-yield tenofovir intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturers globally.
Novel amidation-first route for Capecitabine synthesis improves yield to 68% and purity. Cost-effective supply chain solution for oncology APIs.
Patent CN108069860B details a high-yield Lewis acid-catalyzed bromination route for o-nitrobenzyl bromide, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain stability.
Patent CN111116368B reveals a copper-catalyzed green method for aryl α-keto esters. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical intermediates.
Advanced chiral synthesis patent CN106699604B offers high purity Sacubitril Intermediate. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical partners.
Patent CN116554000B reveals rhodium-catalyzed indenol synthesis. Enhances enantioselectivity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115197188B reveals efficient synthesis of pentacyclic sesquiterpene hydroquinones. Discover cost-effective manufacturing and scalable supply chain solutions.
Discover the patented CN101006064B process for Irbesartan. This report analyzes the novel reductive alkylation route, offering significant cost reduction in API manufacturing and enhanced supply chain stability.
Patent CN110156716B details a novel copper-catalyzed method for benzothiazole esters, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel acid-catalyzed route eliminates transition metals ensuring high purity pharmaceutical intermediates. Significant cost reduction and supply chain reliability for global procurement teams seeking scalable solutions.
Patent CN107325002B details a green Ag/Cu-catalyzed decarboxylative halogenation method. It offers cost reduction in pharmaceutical intermediate manufacturing using cheap halide salts.
Patent CN110885329B reveals a cost-effective synthesis of 1,7-naphthyridine derivatives, eliminating palladium catalysts and toxic reagents for scalable pharmaceutical manufacturing.
Patent CN111646917A details a metal-free route to N-(4-iodophenyl) amides using m-CPBA and HFIP, offering cost reduction and high purity for pharmaceutical intermediates.
Novel method for epoxy compound synthesis using recyclable sulfonates, offering cost reduction and high purity for pharma intermediates.
Patent CN102267985A reveals a scalable route for Vilazodone HCl, eliminating hazardous Lewis acids and precious metals for cost-effective pharmaceutical manufacturing.
Patent CN113816878A reveals a mild cobalt-catalyzed route for alkyl sulfonyl fluorides, offering significant cost reduction and scalability for pharmaceutical manufacturing.